BC@DNA-Mn3(PO4)2 Nanozyme for Real-Time Detection of Superoxide from Living Cells.

Electrochemical in situ sensing of small signal molecules released from living cells has an increasing significance in early diagnosis, pathological analyses, and drug discovery. Here, a living cell-fixed sensing platform was built using the BC@DNA-Mn3(PO4)2 nanozyme, in which a highly biocompatible bacterial cellulose riveted with very tiny Mn3(PO4)2; it not only delivers high catalytic activity toward superoxide anions but possesses excellent biocompatibility for cell adsorption and growth. Additionally, the experimental results suggested that fixing the living cells on the surface of the sensing platform facilitates tiny Mn3(PO4)2 activity centers to capture and detect O2•- very quickly and simultaneously has great potential in miniaturization, cost reduction, and real-time monitoring.

Puzzle-inspired carbon dots coupled with cobalt phosphide for constructing a highly-effective overall water splitting interface.

Inspired by the structure of puzzles, bombyx mori silk-derived carbon dots (CDs) with abundant negative groups, as jigsaw pieces, were combined with nano-CoP to create a highly effective electrocatalytic interface. The hollow cavity and thin wall of the bamboo-like CDs/CoP nanoarray is beneficial to produce more H˙ radicals and accelerate water decomposition.

Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 cases.

BACKGROUND: The role of miR-99a-3p in Head and neck squamous cell carcinoma (HNSCC) has not been reported. Therefore, in this study, we examined the expression level and its molecular mechanisms of miR-99a-3p in HNSCC. MATERIALS AND METHODS: MiR-99a-3p-related miRNA-chip and miRNA-sequencing data were collected. We then carried out meta-analyses to pool the standard mean difference (SMD) value and generate a summarized receiver operating characteristic (sROC) curve. MiR-99a-3p mimic was transfected into FaDu cells and those genes influenced by miR-99a-3p were gathered. The target genes were also predicted from 12 tools through miRwalk2.0, and combined with differentially expressed genes in HNSCC from the The Cancer Genome Atlas and Genotype-Tissue Expression sequencing databases. FunRich and DAVID were used for the pathway signaling analyses for the potential targets of miR-99a-3p in HNSCC. RESULTS: The SMD was -0.30 (95% CI: -0.51, -0.08) in the fixed-effect model and -0.28 (95% CI: -0.67, 0.10) in the random-effect model (I2 = 60%), indicating a reduced expression level of miR-99a-3p in HNSCC tissues based on 1167 cases. In the sROC curve, the area under the curve (AUC) was 0.77 (95% CI: 0.73, 0.81). The 251 potential targets of miR-99a-3p were enriched in several pathways related to cancer, with the "Pathways in cancer" standing at the top. vascular endothelial growth factor A was selected as an example with up-regulated trend in HNSCC tissues. CONCLUSION: MiR-99a-3p exhibits a significant lower expression status in HNSCC, and this reduced or deletion status promotes the malignant progression of HNSCC. However, its molecular mechanism is still unclear and requires further investigation.

Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.

The severe damage to health and social burden caused by head and neck squamous cell carcinoma (HNSCC) generated an urgent need to develop novel anti-cancer therapy. Currently, drug repositioning has risen in responses to the proper time as an efficient approach to invention of new anti-cancer therapies. In the present study, we aimed to screen candidate drugs for HNSCC by integrating HNSCC-related pathways from differentially expressed genes (DEGs) and drug-affected pathways from connectivity map (CMAP). We also endeavored to unveil the molecular mechanism of HNSCC through creating drug-target network and protein-to-protein (PPI) network of component DEGs in key overlapping pathways. As a result, a total of 401 DEGs were obtained from TCGA and GTEx mRNA-seq data. Taking the intersection part of 27 HNSCC-related Kyoto Encyclopedia of Genes and Genomes pathways and 33 drug-affected pathways, we retained 22 candidate drugs corresponding to two key pathways (cell cycle and p53 signaling pathways) of the five overlapping pathways. Two of the hub genes (PCNA and CCND1) identified from the PPI network of component DEGs in cell cycle and p53 signaling pathways were defined as the critical targets of candidate drugs with increased protein expression in HNSCC tissues, which was reported by the human protein atlas (HPA) database and cBioPortal. Finally, we validated via molecular docking analysis that two drugs with unknown effects in HNSCC: MG-262 and bepridil might perturb the development of HNSCC through targeting PCNA. These candidate drugs possessed broad application prospect as medication for HNSCC.

A regulatory mutant on TRIM26 conferring the risk of nasopharyngeal carcinoma by inducing low immune response.

The major histocompatibility complex (MHC) is most closely associated with nasopharyngeal carcinoma (NPC), but the complexity of its genome structure has proven challenging for the discovery of causal MHC loci or genes. We conducted a targeted MHC sequencing in 40 Cantonese NPC patients followed by a two-stage replication in 1065 NPC cases and 2137 controls of Southern Chinese descendent. Quantitative RT-PCR analysis (qRT-PCR) was used to detect gene expression status in 108 NPC and 43 noncancerous nasopharyngeal (NP) samples. Luciferase reporter assay and chromatin immunoprecipitation (ChIP) were used to assess the transcription factor binding site. We discovered that a novel SNP rs117565607_A at TRIM26 displayed the strongest association (OR = 1.909, Pcombined = 2.750 × 10-19 ). We also observed that TRIM26 was significantly downregulated in NPC tissue samples with genotype AA/AT than TT. Immunohistochemistry (IHC) test also found the TRIM26 protein expression in NPC tissue samples with the genotype AA/AT was lower than TT. According to computational prediction, rs117565607 locus was a binding site for the transcription factor Yin Yang 1 (YY1). We observed that the luciferase activity of YY1 which is binding to the A allele of rs117565607 was suppressed. ChIP data showed that YY1 was binding with T not A allele. Significance analysis of microarray suggested that TRIM26 downregulation was related to low immune response in NPC. We have identified a novel gene TRIM26 and a novel SNP rs117565607_A associated with NPC risk by regulating transcriptional process and established a new functional link between TRIM26 downregulation and low immune response in NPC.

[A three-dimensional quantitative measurement related to sigmoid sinus by using multi-slices spiral CT].

OBJECTIVE: To provide a valuable imaging anatomic method for operation of the posterior transpetrosal approach and accurate positioning among relative structures in order to reduce the incidence of surgical complications. METHODS: The clinical information of 119 adult cases (238 sides) was analyzed. All the cases underwent 16 layer helix CT scanning and three-dimensional image reconstruction of skull base without a skull base disease. Axial and coronal images were reconstructed using multiplanar reconstruction technique of ADW 4.2 workstation, and the anatomic objective structure were displayed by rotating imaging slices. The data were analyzed in statistically and compared with the published cadaver data. RESULTS: Quantitative measurement of anatomic structure was shown as below: The distance of width of sigmoid sinus was (11.14 + or - 2.13) mm, the distance of depth of sigmoid sinus was (6.04 + or - 1.67) mm; the distance from the lateral wall of sigmoid sinus to the surface of mastoid process was (9.74 + or - 2.95) mm; the distance from the anterior wall of sigmoid sinus to the posterior wall of external auditory meatus was (12.98 + or - 2.71) mm; the distance from the most posterior portion of the posterior semicircular canal to the anterior wall of sigmoid sinus was (9.87 + or - 2.60) mm; the distance from the most posterior portion of the posterior semicircular canal to the posterior pyramidal wall was (3.18 + or - 1.30) mm; the distance from the posterior extremity of long axis of the lateral semicircular canal to the anterior wall of sigmoid sinus was (13.17 + or - 2.59) mm; the distance from the posterior extremity of long axis of the lateral semicircular canal to the posterior pyramidal wall was (5.46 + or - 1.38) mm; the vertical distance from the lateral semicircular canal to the jugular bulb was (6.69 + or - 3.08) mm; and the distance from the vertical portion of facial nerve to the jugular bulb was (5.32 + or - 2.13) mm. Statistically, there were no significant differences between imaging quantitative measurement and published cadaver data. However, the measurement result, included the distance from the lateral wall of sigmoid sinus to the surface of mastoid process and the distance from the lateral semicircular canal to the jugular bulb as well as the distance from the vertical portion of facial nerve to the jugular bulb, were found a positively correlated to the distance from the anterior wall of sigmoid sinus to the posterior wall of external auditory meatus (r value was 0.284, 0.145, 0.208, respectively, all P < 0.05). CONCLUSIONS: The result of three-dimensional quantitative measurement by using multiplanar reconstruction technique of 16 layer spiral CT could represent a real distance of anatomic structures. The reconstruction of spiral CT images could display a anatomic feature of temporal bone accurately, and it may provide a valuable method for surgical approach and accurate positioning of relative structure in operation. As the location of sigmoid sinus moving forward, the lateral shift of it may occur more easily and the jugular bulb become closer to the vertical portion of facial nerve, while the extension of anterior location in sigmoid sinus should be a positively correlated to the height of jugular bulb.